RUNX2 and melanoma: However, by using parental and RUNT KO melanoma cells, both expressing similar FBXW11 and beta‐catenin levels, we observed that RUNT domain is able to prevent proteasome degradation of RUNX2 regardless of the expression of FBXW11.